Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer

INTRODUCTION: Surgery is the primary treatment for resectable, non-metastatic recurrent head and neck squamous cell carcinoma (HNSCC). We explore the safety and oncologic benefit of intraoperative Cesium-131 (Cs-131) brachytherapy combined with salvage local and/or regional surgical resection. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Luginbuhl, Adam, Calder, Alyssa, Kutler, David, Zender, Chad, Wise-Draper, Trisha, Patel, Jena, Cheng, Michael, Karivedu, Vidhya, Zhan, Tingting, Parashar, Bhupesh, Gulati, Shuchi, Yao, Min, Lavertu, Pierre, Takiar, Vinita, Tang, Alice, Johnson, Jennifer, Keane, William, Curry, Joseph, Cognetti, David, Bar-Ad, Voichita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660666/
https://www.ncbi.nlm.nih.gov/pubmed/34900741
http://dx.doi.org/10.3389/fonc.2021.786216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660666/
https://www.ncbi.nlm.nih.gov/pubmed/34900741
http://dx.doi.org/10.3389/fonc.2021.786216

Ejemplares similares